Overview
Sabah Öney holds the position of Venture Partner at ARCH Venture Partners [1][5]. Öney serves as Chief Executive Officer of Dispatch Bio [3] and as Co-Founder and Board Member of Vilya [4], while also holding a Board of Directors position at Fred Hutch [2]. Previously, Öney worked at Alector as Chief Business Officer from February 2018 to May 2021 [6] and as Vice President of Business Development and Operations from October 2016 to February 2018 [7]. Öney held roles at Ariosa Diagnostics, including Head of Global Sales and Business Development and Director of Business Development between September 2012 and January 2016 [8][9]. Öney earned a Ph.D. in Genetics and Genomics from Duke University [11], a B.S. in Genetics from the University of Kansas [12], and an M.B.A. from Stanford University Graduate School of Business [10].
Career history
- Member Board of DirectorsJan 2026 to presentFred Hutch
- Chief Executive OfficerJun 2023 to presentDispatch Bio
- Co-Founder, Member Board of DirectorsJul 2022 to presentVilya
- Venture PartnerOct 2021 to presentARCH Venture Partners
- Chief Business OfficerFeb 2018 to May 2021Alector
- Vice President, Business Development and OperationsOct 2016 to Feb 2018Alector
- Head of Global Sales and Business DevelopmentOct 2015 to Jan 2016Ariosa Diagnostics [Acquired by Roche]
- Director of Business DevelopmentSep 2012 to Jan 2016Ariosa Diagnostics [Acquired by Roche]
Education
M.B.A.2010 - 2012Stanford University Graduate School of Business
Doctor of Philosophy - PhD, Genetics and GenomicsAug 2003 - May 2008Duke University
B.S., Genetics1999 - 2003The University of Kansas
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.